References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- IsobeYNashimotoAAkazawaKGastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registryGastric Cancer201114430131621894577
- CunninghamDAllumWHStenningSPPerioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerN Engl J Med20063551112016822992
- BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
- CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- MaltoniMCaraceniABrunelliCPrognostic factors in advanced cancer patients: evidence-based clinical recommendations – a study by the Steering Committee of the European Association for Palliative CareJ Clin Oncol200523256240624816135490
- ProctorMJMorrisonDSTalwarDA comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEur J Cancer201147172633264121724383
- ProctorMJMcMillanDCMorrisonDSFletcherCDHorganPGClarkeSJA derived neutrophil to lymphocyte ratio predicts survival in patients with cancerBr J Cancer2012107469569922828611
- GuthrieGJCharlesKARoxburghCSHorganPGMcMillanDCClarkeSJThe systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerCrit Rev Oncol Hematol201388121823023602134
- ParamanathanASaxenaAMorrisDLA systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumoursSurg Oncol2014231313924378193
- PanQXSuZJZhangJHWangCRKeSYA comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancerOnco Targets Ther201581375138526124667
- AbsengerGSzkanderaJPichlerMA derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patientsBr J Cancer2013109239540023820252
- SzkanderaJStotzMEisnerFExternal validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patientsPLoS One2013811e7822524223776
- DiricanAEkinciNAvciAThe effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancerCancer Biomark2013131112023736017
- DiricanAKucukzeybekBBAlacaciogluADo the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?Int J Clin Oncol2015201708124532163
- AzabBBhattVRPhookanJUsefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patientsAnn Surg Oncol201219121722421638095
- ChuaWCharlesKABaracosVEClarkeSJNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBr J Cancer201110481288129521448173
- NobleFHopkinsJCurtisNThe role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancerMed Oncol201330359623690267
- LeeSOhSYKimSHPrognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer20131335023876227
- JinHZhangGLiuXBlood neutrophil-lymphocyte ratio predicts survival for stage III–IV gastric cancer treated with neoadjuvant chemotherapyWorld J Surg Oncol20131111211023281640
- LuoGGuoMLiuZBlood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapyAnn Surg Oncol201522267067625155401
- KaoSCPavlakisNHarvieRHigh blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapyClin Cancer Res201016235805581320956618
- WashingtonK7th edition of the AJCC cancer staging manual: stomachAnn Surg Oncol201017123077307920882416
- SasakiAIwashitaYShibataKMatsumotoTOhtaMKitanoSPrognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinomaSurgery2006139675576416782430
- LeeYYChoiCHSungCOPrognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag levelGynecol Oncol20121241929722014631
- JablonskaEPuzewskaWGrabowskaZJablonskiJTalarekLVEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancerCytokine2005303939915826815
- ArdiVCKupriyanovaTADeryuginaEIQuigleyJPHuman neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProc Natl Acad Sci U S A200710451202622026718077379
- MotomuraTShirabeKManoYNeutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironmentJ Hepatol2013581586422925812
- KantolaTKlintrupKVayrynenJPStage-dependent alterations of the serum cytokine pattern in colorectal carcinomaBr J Cancer2012107101729173623059742